Allele Biotechnology and Pharmaceuticals, Inc. is a San Diego based company with a focus on innovative research in life sciences. Privately owned, Allele Biotech has three lines of business: 1) manufacturing molecular and cell biology reagents, 2) performing custom service projects such as gene cloning and cell line development, and 3) developing novel technologies, particularly in the fields of RNAi, antibody screening, and fluorescent proteins.
Allele was incorporated in 1999 as a biotechnology discovery company. Its research efforts in basic and translational science were mainly supported by grants or contracts from the National Institutes of Health. Ongoing technology projects include RNA interference technologies, RNA signal amplification and detection, antibody selection, and fluorescent protein development. Current basic research focuses on adipocyte development in relation to obesity and diabetes. In 2001, Allele’s R&D efforts yielded a breakthrough in ease-of-use for the broadly applicable RNA interference technique: the Allele LineSilence platform. It offered the first DNA-based RNAi product kit to the market in 2002, which was later exclusively out-licensed to a major marketing partner until 2004.
The Allele Team le Team is comprised of a diverse group of trained professionals in all areas related to our business. Allele’s scientists and research associates are highly regarded in their individual areas of expertise. The customer service and technical support groups are knowledgeable and enthusiastic in helping customers. Most importantly, the close interactions among researchers and customer service staff continue to reinforce the understanding of how biologists would think and require as customers of Allele’s reagents and equipments. Our research tools allow for an infinite amount of possibilities in the world of molecular biology. We are excited to see what the future will bring. We do not just listen, we make things happen.
1999 - Company founded.
2000 - Established R&D facilities.
2001 - Received funding through 3 NIH SBIR grants.
2001 - Launched oligo synthesis service.
2001 - Filed the first patent resulting from R&D activities.
2002 - Patent-pending RNAi technology developed into LineSilence Kits.
2002 - LineSilence Kits launched as the first DNA-based RNAi system.
2003 - Filed patent on novel transfection method.
2003 - Received 2 RNAi-related NIH grants.
2004 - Developed an innovative system for quantitative RNA detection.
2004 - Built a complete product line foromplete product line for Allele’s core RNAi technologies.
2004 - Launched major market expansion with new products and superior customer service.
2005 -Initiated a major market expansion with new products and high level customer service.
2006 - Moved to the current facility in an expansion of business.
2006 - Launched Allele’s first fluorescent protein product, establishing a new product line of higher quality fluorescent proteins for the increasingly demanding needs of cell imaging.
2007 -Allowed for US patent on Allele’s RNAi technology
2007 - US patent issued on special design for inducing RNAi in mammalian cells with modified Pol III promoter
2007 ?Successfully completed a cancer diagnostics antibody development contract for the National Cancer Institute, NIH
2008 - Second US patent issued on broad use of engineered human and mouse U6 promoter to introduce siRNA or shRNA
2008 ?Acquired Orbigen, Inc. and expanded product line to include about 1,000 antibodies and Baculovirus protein expression system
Allele Biotech
9924 Mesa Rim Road
San Diego, CA 92121
Telephone: 858-587-6645
Toll Free: 800- 991- RNAi (7624)
Fax: 858-587-6692
Email: oligo@allelebiotech.com
For our international customers, please visit the following distributor sites in your area
China: Allele Biotech China
Japan: Nacalai Tesque, Inc
Tokyo, Japan: Ar Brown
Japan: Kurabo Biomedical
Seoul, Korea: JC Bio.Co.,Ltd
At Allele Biotechnology & Pharmaceuticals, your talent can touch the lives of people everywhere. Whether you choose an opportunity in research and development, manufacturing, marketing, sales, finance or customer service, you will contribute to the next generation of research tools and breakthroughs that will create amazing discoveries. It is a momentous responsibility shared equally by everyone who chooses to build a career with us. If you are committed to making a significant difference within the scientific community, we invite you to learn more about our business groups, our products and our plans for the future.
If you need further information, please contact us at employment@allelebiotech.com and include a resume if you require a more in depth inquiry.
Thank You.
Allele Biotechnology & Pharmaceuticals, Inc recognizes the importance of protecting the privacy of information we may collect from our on-line visitors. To this end, we are committed to using our best efforts to respect the privacy of our on-line visitors. It is our intent to balance our legitimate business interests in collecting and using information received from and about you with your reasonable expectations of privacy. The following is the way we handle information learned about you from your visit to our website.
Some Allele Biotechnology & Pharmaceuticals, Inc web sites deposit certain bits of information called "cookies" in a visitor's computer. Cookies are sent back only to the web site that deposited them when a visitor returns to that site. Cookies can tell us how and when pages in a website are visited and by how many people. This technology does not collect personal identifiable information; the information collected is in an aggregate, non-identifiable form. With the information we can learn through this technology, we hope to improve our sites. In addition, we gather information about you that is automatically collected by our Web server, such as your IP address and domain name. Allele Biotechnology & Pharmaceuticals may use this information to customize its offerings and presentations. On occasion, we contract with third parties to place cookies on your computer's hard drive. These third parties have entered into an agreement with us that requires them to observe our Privacy Policy.
Personally Identifiable Information
Allele Biotechnology & Pharmaceuticals collects personally identifiable information, such as names, addresses, E-mail addresses and the like, only when voluntarily provided by a website visitor. We will notify you as to the uses we intend to make of that information.
As a resource to our visitors, Allele Biotechnology & Pharmaceuticals provides links to other websites. We try to carefully choose websites which we believe are useful and meet our high standards. However, because websites can change so quickly, we can't guarantee the standards of every website link we provide or be responsible for the content of non-Allele Biotechnology & Pharmaceuticals sites.
Commercial entities may be required to obtain a license from Allele Biotech or a third party in order to purchase certain products, such as fluorescent proteins, certain protein analysis and RNAi reagents. Please refer to product descriptions and contact the Licensing Department of Allele Biotech at 858-587-6645, 800-991-RNAi.
.
Thank You.
|